Top

International Urology and Nephrology

Published in:

01-12-2016 | Nephrology - Original Paper

Assessment of abdominal aortic calcification at different stages of chronic kidney disease

Authors: Zeynep Biyik, Nedim Yilmaz Selcuk, Halil Zeki Tonbul, Melih Anil, Mehmet Uyar

Published in: International Urology and Nephrology | Issue 12/2016

Abstract

Purpose

Vascular calcifications that may cause cardiovascular disease are highly prevalent in chronic kidney disease (CKD). In this study, we aimed to determine abdominal aorta calcifications (AAC) in predialysis and hemodialysis patients by lateral lumbar radiography and to investigate factors that were associated with the calcifications.

Methods

Two hundred and fifty-nine adult chronic hemodialysis patients, 300 predialysis CKD patients and 60 healthy subjects with normal kidney function as a control group were enrolled in the study. Lateral lumbar radiography was used to measure AAC. Calcified deposits of the abdominal aorta wall at the level of the first through fourth lumbar vertebrae were graded by a 24-point scoring system.

Results

AAC prevalence (AAC score ≥1) was significantly different in hemodialysis, predialysis and control groups (71.8, 45.7 and 33.3 %, respectively; p < 0.001). AAC prevalence in CKD stages 1, 2, 3, 4 and 5 predialysis patients was 26.6, 43.3, 40, 58.3 and 55 %, respectively. AAC scores of the hemodialysis group were higher than of the predialysis group (p < 0.001) and the control group (p < 0.001). AAC scores of the predialysis group were not higher than of the control group (p = 0.314). AAC scores of the hemodialysis group were significantly higher than of the control group (p < 0.001) and stage 1 (p < 0.001), stage 2 (p = 0.001) and stage 3 predialysis groups (p = 0.002). Age (p < 0.001), presence of diabetes mellitus (p < 0.001) and serum phosphorus levels (p = 0.011) were found to be independent predictors of calcification in the hemodialysis group. Age (p < 0.001), serum phosphorus levels (p = 0.007) and history of cardiovascular disease (p = 0.014) were found to be independent predictors of calcification in the predialysis group.

Conclusions

Abdominal aortic calcification is highly prevalent in the hemodialysis population. Strict phosphorus control should be implemented to the predialysis and hemodialysis patients.

Foley RN, Parfrey PS, Sarnak MJ (1998) Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 9(12 Suppl):S16–S23PubMed

Keith DS, Nichols GA, Gullion CM et al (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164(6):659–663CrossRefPubMed

Go AS, Chertow GM, Fan D et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296–1305CrossRefPubMed

Muntner P, He J, Hamm L, Loria C et al (2002) Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13(3):745–753PubMed

Goodman WG, London G, Amann K et al (2004) Vascular calcification in chronic kidney disease. Am J Kidney Dis 43(3):572–579CrossRefPubMed

Dellegrottaglie S, Sanz J, Rajagopalan S (2006) Vascular calcification in patients with chronic kidney disease. Blood Purif 24(1):56–62CrossRefPubMed

Bellasi A, Ferramosca E, Muntner P et al (2006) Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 70(9):1623–1628CrossRefPubMed

Okuno S, Ishimura E, Kitatani K et al (2007) Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 49(3):417–425CrossRefPubMed

Wilson PW, Kauppila LI, O’Donnell CJ et al (2001) Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103(11):1529–1534CrossRefPubMed

10.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention (2009) Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int Suppl 113:S1–130

11.

Levey AS, Bosch JP, Lewis JB et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461–470CrossRefPubMed

12.

K/DOQI clinical practice guidelines for chronic kidney disease (2002) evaluation, classification, and stratification. Am J Kidney Dis 39(2 Suppl 1):S1–266

13.

Kauppila LI, Polak JF, Cupples LA et al (1997) New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 132(2):245–250CrossRefPubMed

14.

Braun J, Oldendorf M, Moshage W et al (1996) Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 27(3):394–401CrossRefPubMed

15.

Matsuoka M, Iseki K, Tamashiro M et al (2004) Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 8(1):54–58CrossRefPubMed

16.

Qunibi WY, Abouzahr F, Mizani MR et al (2005) Cardiovascular calcification in Hispanic Americans (HA) with chronic kidney disease (CKD) due to type 2 diabetes. Kidney Int 68(1):271–277CrossRefPubMed

17.

Fox CS, Larson MG, Keyes MJ et al (2004) Kidney function is inversely associated with coronary artery calcification in men and women free of cardiovascular disease: the Framingham Heart Study. Kidney Int 66(5):2017–2021CrossRefPubMed

18.

Hanada S, Ando R, Naito S et al (2010) Assessment and significance of abdominal aortic calcification in chronic kidney disease. Nephrol Dial Transplant 25(6):1888–1895CrossRefPubMed

19.

Garcia-Canton C, Bosch E et al (2011) Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5. Nephrol Dial Transplant 26(7):2250–2256CrossRefPubMed

20.

Honkanen E, Kauppila L, Wikstrom B et al (2008) Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 23(12):4009–4015CrossRefPubMedPubMedCentral

21.

Toussaint ND, Pedagogos E, Lau KK et al (2011) Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients. Nephrology (Carlton) 16(4):389–395CrossRef

22.

Temmar M, Liabeuf S, Renard C et al (2010) Pulse wave velocity and vascular calcification at different stages of chronic kidney disease. J Hypertens 28(1):163–169CrossRefPubMed

23.

Moe SM, O’Neill KD, Fineberg N et al (2003) Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 18(6):1152–1158CrossRefPubMed

24.

London GM, Guerin AP, Marchais SJ et al (2003) Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 18(9):1731–1740CrossRefPubMed

25.

Mehrotra R, Budoff M, Christenson P et al (2004) Determinants of coronary artery calcification in diabetics with and without nephropathy. Kidney Int 66(5):2022–2031CrossRefPubMed

26.

Yamada K, Fujimoto S, Nishiura R et al (2007) Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephrol Dial Transplant 22(7):2032–2037CrossRefPubMed

27.

Tentori F, Blayney MJ, Albert JM et al (2008) Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52(3):519–530CrossRefPubMed

28.

Goodman WG, Goldin J, Kuizon BD et al (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342(20):1478–1483CrossRefPubMed

29.

Raggi P, Boulay A, Chasan-Taber S et al (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39(4):695–701CrossRefPubMed

30.

Shigematsu T, Kono T, Satoh K et al (2003) Phosphate overload accelerates vascular calcium deposition in end-stage renal disease patients. Nephrol Dial Transplant 18(Suppl 3):86–89

31.

Goldsmith DJ, Covic A, Sambrook PA, Ackrill P (1997) Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Nephron 77(1):37–43CrossRefPubMed

32.

Toussaint ND, Lau KK, Strauss BJ et al (2009) Relationship between vascular calcification, arterial stiffness and bone mineral density in a cross-sectional study of prevalent Australian haemodialysis patients. Nephrology (Carlton) 14(1):105–112CrossRef

33.

Toussaint ND, Lau KK, Strauss BJ et al (2008) Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23(2):586–593CrossRefPubMed

34.

Kestenbaum B, Sampson JN, Rudser KD et al (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16(2):520–528CrossRefPubMed

Title: Assessment of abdominal aortic calcification at different stages of chronic kidney disease
Authors: Zeynep Biyik
Nedim Yilmaz Selcuk
Halil Zeki Tonbul
Melih Anil
Mehmet Uyar
Publication date: 01-12-2016
Publisher: Springer Netherlands
Published in: International Urology and Nephrology / Issue 12/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI: https://doi.org/10.1007/s11255-016-1413-x

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2016

The new Asian modified CKD-EPI equation leads to more accurate GFR estimation in Chinese patients with CKD

Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma

Nested case–control study reveals increased levels of urinary proteins from human kidney toxicity panels in women predicted to develop preeclampsia

A novel technique for repair of mid-penile hypospadias using a preputial skin flap: results of 110 patients

Diagnosis and management of testicular rupture after blunt scrotal trauma: a literature review

Modified ureteral orthotopic reimplantation method for managing infant primary obstructive megaureter: a preliminary study

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials